HEPATITIS C TRIPLE THERAPY INDUCED ANEMIA. IS TREATMENT WITH ERYTHROPOIETIN JUSTIFIED?

被引：0
|
作者：
Alvarez-Male, T. [1 ]
Lopez-Rodriguez, R. [1 ]
Borque, M. J. [2 ]
Rodriguez-Munoz, Y. [1 ]
Hernandez-Bartolome, A. [1 ]
Gonzalez-Moreno, L. [1 ]
Real, Y. [1 ]
Moreno-Otero, R. [1 ]
Sanz-Cameno, P. [1 ]
Garcia-Buey, L. [1 ]
机构：
[1] UAM, Hosp Univ La Princesa, Hepatol Unit, Dept Digest Med, Madrid, Spain
[2] UAM, Mol Biol Unit, CIBERehd, IIS IP,Hosp Univ La Princesa, Madrid, Spain
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60788-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
786
引用
收藏
页码：S320 / S320
页数：1
相关论文
共 50 条
  • [41] Use of hematopoietic growth factors as adjuvant therapy for anemia and neutropenia in the treatment of hepatitis C
    Santos, Anne E. Dar
    Partovi, Nilufar
    Ford, Jo-Ann E.
    Yoshida, Eric M.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (02) : 268 - 275
  • [42] Pathogenesis and therapy of a new model of SOD2 deficiency induced sideroblastic anemia.
    Martin, FM
    Welsh, ML
    Friedman, J
    BLOOD, 2004, 104 (11) : 13B - 13B
  • [43] UTILITY OF ITPA GENOTYPING TO PREDICT EARLY SEVERE ANEMIA IN CHRONIC HEPATITIS C PATIENTS RECEIVING TRIPLE THERAPY
    Camos, S.
    Buti, M.
    Serra, M. A.
    Rodriguez-Frias, F.
    Escudero, A.
    Homs, M.
    Rodriguez, F.
    Tabernero, D.
    Esteban, R.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S327 - S327
  • [44] The role of triple therapy (interferon, ribavirin and amantadine) in the treatment of chronic hepatitis C.
    Vlodov, J
    Charania, M
    Jose, RM
    Iswara, K
    Lapin, S
    Terebelo, S
    Bernstein, M
    Tenner, S
    HEPATOLOGY, 2000, 32 (04) : 565A - 565A
  • [45] Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir
    Moradpour, Darius
    Muellhaupt, Beat
    SWISS MEDICAL WEEKLY, 2012, 142
  • [46] Triple therapy for chronic Hepatitis C Serum ferritin levels are influenced Treatment success
    Schulz-Hanke, Ines
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2012, 50 (08): : 728 - 728
  • [47] A case of successful treatment with telaprevir-based triple therapy for hepatitis C infection after treatment failure with vaniprevir-based triple therapy
    Takayama, Koji
    Furusyo, Norihiro
    Ogawa, Eiichi
    Shimizu, Motohiro
    Hiramine, Satoshi
    Mitsumoto, Fujiko
    Ura, Kazuya
    Toyoda, Kazuhiro
    Murata, Masayuki
    Hayashi, Jun
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (9-10) : 577 - 581
  • [48] Ribavirin-induced anemia: Incidence and impact to treatment response of chronic hepatitis C
    Leerapun, Apinya
    Soontornpun, Atiwat
    Pisespongsa, Pises
    Chitapanarux, Taned
    Kijdamrongthum, Phuripong
    Thongsawat, Satawat
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 267 - 267
  • [49] Triple therapy for chronic hepatitis C: Practical Aspects
    Bakulin, I. G.
    Kiseleva, A. V.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (11) : 91 - 99
  • [50] Evaluation of Dual Versus Triple Therapy for Hepatitis C
    Brown, Nicol D.
    Browne, Barry A.
    Kim, Christine
    Jo, Chanhee
    Sears, Dawn
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2014, 6 (06) : 270 - 276
12345